Phase 2 Clinical Trial Prostate Cancer Treatment
FILTERS
TOPICS
CritiTech PES partner NanOlogy Enrolls First Patient in Phase 2 Clinical Trial of NanoPac® for Intratumoral Treatment of Prostate Cancer
Follows completion of a first-in-human dose-rising study of a single focal injection of NanoPac in patients with local prostate cancer … Continued
More >